Therefore, we believe that an increased proportion of cytokine-producing CD8+ T cells may confer enhanced protection in the pulmonary compartment, emphasizing once again that targeting CD8+ T cells should be considered as a strategy for developing novel TB vaccines. The gene discussed is CD8A; the disease is tuberculosis.